Neomycin N-30), Polymyxins (Colistin sulfate CL-10 ug), Amphotericols (Florfenicol FFC-30 ug), Cephalosporins (Cefotaxime CTX-30 ug), Beta lactams (Ampicillin AMP-10 ug, Amoxycillin AX-25), Tetracyclines (Tetracycline TE-30 ug, Doxycycline DO-30 ug), Sulphonamides (Trimethoprim-sulfamethoxazole COT, 25 g), Macrolides (Spiramycin SP-100) and Lincosamides (Lincomycin L-2)
FDA accepted the clarification and restored the non-injectable listing in its May 14 document update
164 Conversely, the loss of CYP3A4 expression in hepatocellular carcinoma impairs the bioactivation of prodrugs, leading to treatment failure
, , - ,
Every injection is performed in a clean, sterile setting with single-use needles and proper skin preparation to reduce the risk of infection, a risk that is higher with at-home kits